facebook_pixel

Options Strategies

Options Strategy 10 October 2013
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Gilead Sciences Nov $65 Calls: Buy To Profit From Idelalisib & Sofosbuvir

Gilead Sciences Nov $65 Calls: Buy To Profit From Idelalisib & Sofosbuvir

* NOTE: The Following Call Options Buy Strategy Is ONLY For Investors Who Can Afford Short Term Price Risk & Volatility * Gilead Sciences Inc., the world’s largest biotechnology company by market value, gained the most in five months after patients benefited enough from the cancer drug idelalisib to end a late-stage study early * […]

FIND OUT MORE

Options Strategy 3 October 2013
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
JPMorgan: Buy Oct $52.50 Call Options To Profit From Earnings On Oct 11

JPMorgan: Buy Oct $52.50 Call Options To Profit From Earnings On Oct 11

* NOTE: This is a high risk option trade meant ONLY for Investors who can afford short term price risk and volatility * JPMorgan Chase & Co. fended off a resurgent Citigroup Inc. to remain the biggest arranger of corporate-bond sales worldwide for the eighth straight quarter as the top three underwriters took the biggest […]

FIND OUT MORE